Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Mult Scler Relat Disord ; 48: 102692, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33352358

ABSTRACT

BACKGROUND: The Minimal Assessment of Cognitive Function in Multiple sclerosis (MACFIMS) is an internationally recognised battery of neuropsychological tests for patients with multiple sclerosis (MS). OBJECTIVES: To establish regression-based norms for the MACFIMS in French-speaking healthy subjects (HS) and validate its use in persons with multiple sclerosis (PwMS). METHODS: 136 PwMS, including 43 with relapsing-remitting MS, 46 with secondary progressive MS and 45 with primary progressive MS, as well as 276 HS were enrolled. Regression-based norms and validity were established for the seven tests of the MACIMS: the Symbol Digit Modalities Test (SDMT), the Paced Auditory Serial Addition Test (PASAT), the French learning test (FLT) a French-adapted memory test (or the California Verbal Learning Test (CVLT) at re-testing), the Judgment of Line Orientation Test (JLO), the 'épreuve de classement de cartes de Champagne' (ECCC), a French adaptation of the DKEF-sorting test, the Brief Visuospatial Memory Test (BVMT-R) and the Controlled Oral Word Association Test (COWAT). RESULTS: Regression-based norms of MACFIMS tests were established in the HS population. The MACFIMS battery was able to identify cognitive impairment (CI) (at least two abnormal tests in different domains) in 32.7% of PwMS. The domains with more frequent impairment were (in descending order): learning followed by IPS, delayed memory, verbal fluency and working memory. CONCLUSION: This study established the regression-based norms for French subjects of the French adaptation of the MACFIMS and its validity in PwMS.


Subject(s)
Cognition Disorders , Multiple Sclerosis, Chronic Progressive , Multiple Sclerosis , Cognition , Humans , Multiple Sclerosis/complications , Multiple Sclerosis/diagnosis , Multiple Sclerosis, Chronic Progressive/diagnosis , Neuropsychological Tests
2.
PLoS One ; 12(1): e0168834, 2017.
Article in English | MEDLINE | ID: mdl-28045953

ABSTRACT

BACKGROUND: Therapeutic options are limited in secondary progressive multiple sclerosis (SPMS). Open-label studies suggested efficacy of monthly IV cyclophosphamide (CPM) without induction for delaying progression but no randomized trial was conducted so far. OBJECTIVE: To compare CPM to methylprednisolone (MP) in SPMS. METHODS: Randomized, double-blind clinical trial on two parallel groups. Patient with SPMS, with a documented worsening of the Expanded Disability Status Scale (EDSS) score during the last year and an EDSS score between 4·0 and 6·5 were recruited and received one intravenous infusion of treatment (CPM: 750 mg /m2 body surface area-MP: 1g) every four weeks for one year, and every eight weeks for the second year. The primary endpoint was the time to EDSS deterioration, when confirmed sixteen weeks later, analyzed using a Cox model. RESULTS: Due to recruitment difficulties, the study was terminated prematurely after 138 patients were included (CPM, n = 72; MP, n = 66). In the CPM group, 33 patients stopped treatment prematurely, mainly due to tolerability, compared with 22 in the MP group. Primary endpoint: the hazard ratio for EDSS deterioration in the CPM in comparison with the MP group was 0.61 [95% CI: 0·31-1·22](p = 0·16). According to the secondary multistate model analysis, patients in the CPM group were 2.2 times more likely ([1·14-4.29]; p = 0.02) to discontinue treatment than those in the MP group and 2.7 times less likely (HR = 0.37, 95% CI: 0.17-0.84; p = 0.02) to experience disability progression when they did not stop treatment prematurely. Safety profile was as expected. CONCLUSION: Although the primary end-point was negative, secondary analysis suggested that CPM decreases the risk of progression in SPMS, but its use may be limited by low tolerability. TRIAL REGISTRATION: Clinicaltrials.gov NCT00241254.


Subject(s)
Cyclophosphamide/therapeutic use , Methylprednisolone/therapeutic use , Multiple Sclerosis, Chronic Progressive/drug therapy , Adolescent , Adult , Aged , Anti-Inflammatory Agents/therapeutic use , Disabled Persons , Disease Progression , Double-Blind Method , Female , France , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Proportional Hazards Models , Severity of Illness Index , Young Adult
3.
J Neurol Sci ; 354(1-2): 51-5, 2015 Jul 15.
Article in English | MEDLINE | ID: mdl-25977107

ABSTRACT

BACKGROUND: The independent prognostic value of cerebrospinal fluid analysis in multiple sclerosis is not established. OBJECTIVE: To determine the prognostic value of intrathecal synthesis in a cohort of patients with relapsing-onset MS taking into consideration demographic and imaging parameters. METHODS: In this prospective cohort study conducted from 1993 to 2013, we analyzed the time to confirmed disability (persistent above 6 months) and irreversible disability (persistent for the entire disease course) of two disability milestones, Expanded Disability Status Scale score ≥ 4 or 6, and the time to secondary progressive onset in 579 patients with relapsing-onset multiple sclerosis. Demographic parameters (age at onset, gender) and imaging parameters (periventricular lesions) were included in the Cox models. RESULTS: 447 patients (77.2%) had intrathecal synthesis (oligoclonal bands and/or increased immunoglobulin G index value). No statistically significant relation was found between intrathecal synthesis and the time to reach each disability milestone or secondary progressive onset. An age older than 40 years and more than 3 periventricular lesions predicted a worse prognosis. CONCLUSIONS: Cerebrospinal fluid analysis did not predict the time to disability milestones in relapsing-onset multiple sclerosis independently of age and imaging data.


Subject(s)
Disabled Persons , Magnetic Resonance Imaging/methods , Multiple Sclerosis/cerebrospinal fluid , Multiple Sclerosis/diagnosis , Adult , Biomarkers/cerebrospinal fluid , Cohort Studies , Early Diagnosis , Female , Follow-Up Studies , Humans , Male , Multiple Sclerosis/metabolism , Predictive Value of Tests , Prospective Studies , Retrospective Studies , Time Factors
4.
J Neurol Sci ; 347(1-2): 246-50, 2014 Dec 15.
Article in English | MEDLINE | ID: mdl-25454642

ABSTRACT

OBJECTIVE: The aim of this work is to study the relationship between information processing speed (IPS) impairment and motor testing that reflects cerebellar function in persons with multiple sclerosis (PwMS). METHODS: 60 persons with relapsing-remitting multiple sclerosis with a mean disease duration of 4.2 ± 4 years were studied cross-sectionally. Motor cerebellar functioning was studied using the Nine-Hole Peg Test (NHPT) and the Kurtzke Functional Status Scales, and several cognitive domains were evaluated (IPS, working memory, episodic memory, attention, executive function). Correlations between the global NHPT score and neuropsychological test scores or impairment in each cognitive domain were studied using univariate and multivariate analyses. RESULTS: The NHPT and a test of IPS significantly differentiated PwMS with and without cerebellar impairment. The NHPT total score was correlated with measures of IPS. Multivariate analyses showed a correlation between the NHPT and measures of IPS, but not between the NHPT and other neuropsychological tests that did not have a speed component. CONCLUSION: In this sample of PwMS, motor cerebellar impairment assessed by the NHPT was correlated with IPS impairment.


Subject(s)
Cerebellar Diseases/physiopathology , Mental Processes , Motor Activity , Multiple Sclerosis, Relapsing-Remitting/physiopathology , Multiple Sclerosis, Relapsing-Remitting/psychology , Reaction Time , Adult , Attention , Cognition , Executive Function , Female , Humans , Male , Memory, Short-Term , Middle Aged , Neuropsychological Tests , Severity of Illness Index
5.
Mult Scler ; 19(12): 1665-72, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23459569

ABSTRACT

BACKGROUND: Cognitive impairment in multiple sclerosis (MS) primarily applies to information processing speed (IPS). OBJECTIVE: To evaluate psychometric properties of a new digit/symbol substitution test in healthy subjects and patients with MS, and assess its ability to detect IPS impairment in patients with MS. METHODS: A sample of MS patients, 60 relapsing-remitting (RRMS) and 41 primary progressive MS (PPMS), and 415 healthy controls (HCs) underwent an IPS battery, including assessment of reaction times of subtests of the Test of Attentional Performance battery and a newly developed in-house digit/symbol substitution task, the Computerised Speed Cognitive Test (CSCT). The CSCT was additionally evaluated in a second cohort of 31 RRMS and 12 progressive MS patients, for comparison with the Symbol Digit Modalities Test (SDMT). RESULTS: The CSCT had good reliability in both HCs and patients with MS. It showed a weak practice effect at the 6-month time point. This test had good ecological validity in MS patients. There was a strong correlation between the CSCT with the SDMT and with other IPS tests in patients with MS. The CSCT had the best sensitivity for predicting IPS impairment and was one of the most accurate tests among the IPS battery. CONCLUSION: The CSCT appeared as a good candidate for detecting IPS impairment in MS patients.


Subject(s)
Cognition Disorders/etiology , Mental Processes , Multiple Sclerosis/psychology , Neuropsychological Tests , Adolescent , Adult , Affect , Aged , Aging/psychology , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Computers , Educational Status , Fatigue/psychology , Female , Humans , Male , Middle Aged , Multiple Sclerosis/complications , Multiple Sclerosis/physiopathology , Neurologic Examination , Phenotype , Predictive Value of Tests , Psychometrics , Psychomotor Performance , Reaction Time , Reproducibility of Results , Sex Characteristics , Young Adult
6.
Mult Scler ; 17(3): 312-8, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21071465

ABSTRACT

OBJECTIVES: To identify predictors of conversion to definite multiple sclerosis (MS) in patients with a cord clinically isolated syndrome. METHODS: The predictive values for conversion to MS of clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) variables in 114 patients with acute partial myelitis confirmed by a spinal cord lesion on MRI were studied. Other causes of cord syndromes were excluded. RESULTS: MS was diagnosed in 78 patients (86%) during 4.0 ± 1.9 years of follow-up. Some 67 of these patients had a second clinical episode. The diagnosis of isolated myelitis was maintained for 36 patients, 78% of whom (28 cases) were followed for at least 2 years, comparable to the MS patients. Age, bladder involvement, ≥ 2 cord lesions on MRI, ≥ 9 brain lesions, ≥ 3 periventricular lesions and intrathecal IgG synthesis predicted conversion to clinically definite MS. Multivariate logistic analysis identified three predictors of MS diagnosis: age ≤ 40 years, inflammatory CSF and ≥ 3 periventricular lesions on brain MRI. CONCLUSION: Two out of three baseline factors (age, periventricular lesions and inflammatory CSF) predicted conversion to MS with better accuracy than the revised McDonald criteria for dissemination in space.


Subject(s)
Demyelinating Diseases/complications , Multiple Sclerosis/etiology , Adolescent , Adult , Age Factors , Biomarkers/cerebrospinal fluid , Brain/immunology , Brain/pathology , Demyelinating Diseases/cerebrospinal fluid , Demyelinating Diseases/diagnosis , Female , France , Humans , Inflammation Mediators/cerebrospinal fluid , Logistic Models , Magnetic Resonance Imaging , Male , Middle Aged , Multiple Sclerosis/cerebrospinal fluid , Multiple Sclerosis/diagnosis , Odds Ratio , Retrospective Studies , Risk Assessment , Risk Factors , Spinal Cord/immunology , Spinal Cord/pathology , Time Factors , Young Adult
7.
Neuroimage ; 47(2): 659-66, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19409501

ABSTRACT

Hydrocephalus features include ventricular dilatation and periventricular edema due to transependymal resorption of cerebrospinal fluid (CSF). Aquaporin 4 (AQP4), a water channel protein located at the blood-brain barrier, might facilitate the removal of this excess of water from the parenchyma into the blood. First, we hypothesized a link between AQP4 expression and the severity of hydrocephalus. We further hypothesized that movements of water through AQP4 could affect apparent diffusion coefficient (ADC) measurements. Communicating inflammatory hydrocephalus was induced in 45 rats, and at various stages, magnetic resonance imaging (MRI) was used to measure CSF volume and periventricular ADC, with immunostaining being used to determine periventricular AQP4. We found an up-regulation of periventricular AQP4 in hydrocephalic rats that was strongly correlated with both CSF volume (Pearson=0.87, p<0.00001) and periventricular ADC (Pearson=0.85, p<0.00001). AQP4 were first located on astrocyte endfeet, but later on the whole membrane of astrocytes that became hypertrophic in the most severe and chronic hydrocephalic rats. These results show that AQP4 expression follows an adaptative profile to the severity of hydrocephalus, which is probably a protective response mechanism. They also suggest that ADC, on top of informing about cell sizes and interstitial bulk water, might also indirectly reflect quantitative water channel expression.


Subject(s)
Aquaporin 4/metabolism , Body Water/metabolism , Brain/metabolism , Hydrocephalus/metabolism , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Water/metabolism , Animals , Male , Rats , Rats, Wistar , Tissue Distribution
8.
Clin J Pain ; 25(3): 211-7, 2009.
Article in English | MEDLINE | ID: mdl-19333171

ABSTRACT

BACKGROUND: Pain is a frequent symptom during the course of multiple sclerosis (MS) but its frequency and impact at the early clinical stages remain unknown. OBJECTIVES: The aim of this study was to establish prevalence and severity of pain in a cohort of patients recently diagnosed with MS and to determine the evolution of pain prevalence over 2 years. Other objectives were to investigate the presence of baseline clinical predictors of pain after 2 years and to establish its impact on quality of life (QOL). METHODS: In a population-based sample of 69 patients recently diagnosed with MS (<6 mo), pain was measured using questions from the SEP-59 QOL questionnaire. A standardized bedside neurologic examination was performed to establish sensory function, sensory Kurtzke functional system score, and disability scales. Patients were reassessed after 1 and 2 years. RESULTS: Pain was reported by 73.5% of MS patients at baseline and by 70.6% and 61.8% at 1 and 2-year follow-ups, respectively. Clinically significant pain (grades between 3 and 6 using a 6-graded verbal scale) was reported by 63.2% of patients at baseline and by 51.5% and 45.6%, at 1 and 2-year follow-ups, respectively. Pain significantly altered daily activities in 44% of patients. Low overall QOL scores were significantly associated with pain. At 2 years time point, occurrence of pain was associated with baseline depressive symptoms after controlling for the presence of pain at baseline. CONCLUSIONS: Pain is frequent in the early stages of MS and affects the daily QOL.


Subject(s)
Multiple Sclerosis/complications , Multiple Sclerosis/psychology , Pain/etiology , Pain/psychology , Quality of Life/psychology , Adult , Cohort Studies , Disability Evaluation , Disease Progression , Fatigue/etiology , Female , Humans , Longitudinal Studies , Male , Middle Aged , Multiple Sclerosis/diagnosis , Pain Measurement , Statistics, Nonparametric , Surveys and Questionnaires , Young Adult
9.
Hum Brain Mapp ; 30(4): 1133-43, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18465748

ABSTRACT

Recent imaging studies have evidenced various cerebral patterns dependent on educational level during cognitive tasks in neurodegenerative diseases. Determining relationships between educational status and cerebral activation during cognitive demands in physiological conditions may help to better understand the role of education on cognitive efficacy and functional reorganisation in pathological conditions. We proposed to analyse by functional MRI (fMRI) the relationship between educational status and cerebral activation during various attentional requests in healthy young adults. Twenty healthy young adults completed four successive conditions of a Go/No-go test of increasing complexity under fMRI. An effect of education was observed on attentional performances. Both in-scanner response times and cerebral activation increased during the Go/No-go paradigm. Healthy subjects with higher education exhibited higher activity in cerebellum and lower activity in medial prefrontal and inferior parietal regions compared with the healthy subjects with lower educational levels while performing the conditions of Go/No-go task. Our data evidence the influence of education on automatized strategies in healthy adults by modulating a functional balance of activation between cerebral cortex and cerebellar regions during attentional processes.


Subject(s)
Attention/physiology , Cerebellum/physiology , Cerebral Cortex/physiology , Educational Status , Adult , Brain Mapping , Cerebellum/blood supply , Cerebral Cortex/blood supply , Decision Making/physiology , Female , Humans , Image Processing, Computer-Assisted/methods , Intelligence , Magnetic Resonance Imaging/methods , Male , Neuropsychological Tests , Oxygen/blood , Statistics as Topic , Young Adult
10.
J Physiol ; 578(Pt 2): 439-50, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17068103

ABSTRACT

Multiple sclerosis (MS) is characterized by inflammatory lesions throughout the central nervous system. Spinal cord inflammation correlates with many neurological defecits. Most MS patients suffer from micturition dysfunction with urinary incontinence and difficulty in emptying the bladder. In experimental autoimmune encephalomyelitis (EAE) induced in female Lewis rats, a model of MS, we investigated at distinct clinical severity scores the micturition reflex by cystometrograms. All rats presenting symptomatic EAE suffered from micturition reflex alterations with either detrusor areflexia or hyperactivity. During pre-symptomatic EAE, a majority of rats presented with detrusor areflexia, whereas at onset of clinical EAE, detrusor hyperactivity was predominant. During progression of EAE, detrusor areflexia and hyperactivity were equally expressed. Bladder hyperactivity was suppressed by activation of glycine and GABA receptors in the lumbosacral spinal cord with an order of potency: glycine > GABA(B) > GABA(A). Detrusor areflexia was transformed into detrusor hyperactivity by blocking glycine and GABA receptors. Spinalization abolished bladder activity in rats presenting detrusor hyperactivity and failed to induce activity in detrusor areflexia. Altogether, the results reveal an exaggerated descending excitatory control in both detrusor reflex alterations. In detrusor areflexia, a strong segmental inhibition dominates this excitatory control. As in treatment of MS, electrical stimulation of sacral roots reduced detrusor hyperactivity in EAE. Blockade of glycine receptors in the lumbosacral spinal cord suppressed the stimulation-induced inhibitory effect. Our data help to better understand bladder dysfunction and treatment mechanisms to suppress detrusor hyperactivity in MS.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/physiopathology , Reflex, Abnormal/physiology , Urinary Bladder, Neurogenic/physiopathology , Animals , Baclofen/administration & dosage , Baclofen/pharmacology , Bicuculline/pharmacology , Cauda Equina/drug effects , Cauda Equina/physiopathology , Efferent Pathways/drug effects , Efferent Pathways/physiopathology , Electric Stimulation , Encephalomyelitis, Autoimmune, Experimental/etiology , Female , Glycine/administration & dosage , Glycine/pharmacology , Injections, Spinal , Lumbosacral Plexus/physiopathology , Models, Biological , Muscimol/administration & dosage , Muscimol/pharmacology , Peripheral Nerves/physiopathology , Rats , Rats, Inbred Lew , Receptors, Glycine/antagonists & inhibitors , Reflex, Abnormal/drug effects , Spinal Cord/drug effects , Spinal Cord/physiopathology , Strychnine/pharmacology , Urinary Bladder/drug effects , Urinary Bladder/physiopathology , Urinary Bladder, Neurogenic/therapy , Urinary Bladder, Overactive/physiopathology , Urinary Bladder, Overactive/therapy , Urinary Retention/physiopathology , gamma-Aminobutyric Acid/administration & dosage , gamma-Aminobutyric Acid/pharmacology
11.
J Neurol Sci ; 251(1-2): 23-8, 2006 Dec 21.
Article in English | MEDLINE | ID: mdl-17097108

ABSTRACT

BACKGROUND: Cognitive compensatory mechanisms may limit the cognitive dysfunction due to cerebral tissue destruction in multiple sclerosis (MS). OBJECTIVE: To explore the effect of educational status on cognitive performances in early relapsing-remitting (RR) MS. METHODS: 43 RRMS patients were individually matched for age, sex and educational level with 43 healthy controls. Each patient underwent neuropsychological tests, clinical assessment and magnetic resonance imaging (MRI). Cognitive scores of MS patients were compared to those of their paired controls according to educational level. RESULTS: Less educated patients had low performances on all but two neuropsychological tests, while more educated patients had low scores only for three tests. Cognitive performances of more educated patients but not those of less educated ones were strongly correlated with MRI parameters and decreased with the severity of cerebral tissue destruction. CONCLUSION: These different cognitive patterns suggest the existence of a cognitive compensation in more educated patients which is limited by the accumulation of tissue damage.


Subject(s)
Cognition/physiology , Educational Status , Multiple Sclerosis, Relapsing-Remitting/physiopathology , Multiple Sclerosis, Relapsing-Remitting/psychology , Adult , Case-Control Studies , Depression/etiology , Disability Evaluation , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/pathology , Neuropsychological Tests
12.
Mult Scler ; 10(5): 540-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15471371

ABSTRACT

Large inflammatory infiltrates of T cells, macrophages and B cells in the central nervous system (CNS) contribute to the pathogenesis of multiple sclerosis (MS). The passage of T cells through the blood-brain barrier can be suppressed with antibodies directed against alpha-4 integrins (VLA-4) that mediate T-cell adherence. This treatment, in phase III of clinical trial evaluation, reduces lesion development in MS patients. In the ongoing inflammatory disease process the consequences of T-cell inhibitory anti-VLA-4 antibodies on inflammatory compounds are still poorly investigated. We show that anti-VLA-4 antibody treatment during the late preclinical phase of the acute experimental autoimmune encephalomyelitis (EAE) MS rat model interrupts T-cell egress out of the vascular compartment and suppresses clinical disease and histological alterations but macrophage recruitment in the CNS is not fully compromised. Among the treated EAE animals not developing disease, none presented foci of T-cell infiltration in CNS. However, in 75% of the treated EAE rats monocyte ingress in CNS was observed in vivo by magnetic resonance imaging with the ultrasmall superparamagnetic iron oxide contrast agent. Our data shed new light on the role of remaining macrophage brain infiltration in an induced but interrupted T-cell-mediated EAE disease process.


Subject(s)
Antibodies, Monoclonal/pharmacology , Encephalomyelitis, Autoimmune, Experimental , Integrin alpha4beta1/immunology , Macrophages/immunology , T-Lymphocytes/immunology , Acute Disease , Animals , Antibodies, Monoclonal, Humanized , Biomarkers , Contrast Media , Cysteine , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Epitopes/immunology , Female , Ferric Compounds , Macrophages/pathology , Magnetic Resonance Imaging , Monocytes/immunology , Monocytes/pathology , Natalizumab , Rats , Rats, Inbred Lew , Serum Albumin, Bovine , T-Lymphocytes/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...